Maybe they can do additional studies to determine why this 16.6% group offered excellent outcome? Since Multistem has also been proven to be safe- if I were a patient that was stricken by a serious illness- be it stroke, cancer, etc- I would be willing to give it a shot over doing nothing.
It really doesn't matter and he knows nothing- just playing the probability that more small biotech companies fail than succeed. If you go with those odds- you are probably right 85% of the time. If the results are great - the stock price will soar - IMO $10+, if they are good ~ $7, mixed - some good results but some negative data $4, Bad Results $1.
Everyone is going to have their own opinion, but no one really knows the results- even management might not fully know but they may be able to infer based on what they are seeing during trials. Best of luck to everyone- just don't risk more than you can afford to lose.
Agreed- some might have jumped on board expecting a run-up which drove the price up a little, but when it didn't move a lot many of those looking for a quick short term gain bounced. While more small biotech companies fail then succeed- I like how everything is set in place for ATHX. I am keeping my chips in the game until after the results- going in with my eyes wide open that it could all be cleared out. Only investing what I can afford to lose-expecting the worst but hoping for the best.